Agostinelli, C., Gallamini, A., Stracqualursi, L., Agati, P., Tripodo, C., Fuligni, F., Sista, M. T., Fanti, S., Biggi, A., Vitolo, U., Rigacci, L., Merli, F., Patti, C., Romano, A., Levis, A., Trentin, L., Stelitano, C., Borra, A., Piccaluga, P. P. ... Pileri, S. A. (2016).
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
The Lancet Haematology,
3(10), e467-e479.
https://doi.org/10.1016/S2352-3026(16)30108-9
Johnson, PWM., Federico, M., Kirkwood, AA., Fossa, A., Berkahn, L., Carella, AM.
, D'Amore, F. A., Enblad, G., Franceschetto, A., Fulham, M., Luminari, S., O'Doherty, M., Patrick, P., Roberts, T., Sidra, G., Stevens, L., Smith, P., Trotman, J., Viney, Z. ... Barrington, SF. (2016).
Treatment adaptation guided by interim PET scan in advanced Hodgkin lymphoma.
The New England Journal of Medicine,
374(25), 2419-29.
https://doi.org/10.1056/NEJMoa1510093.
Gang, A. O., Pedersen, M.
, d'Amore, F., Pedersen, L. M., Jensen, B. A., Jensen, P., Møller, M. B., Mourits-Andersen, H. T., Pedersen, R. S., Klausen, T. W. & de N Brown, P. (2015).
A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry.
Leukemia and Lymphoma,
56(9), 2556-2562.
https://doi.org/10.3109/10428194.2015.1010078
Ludvigsen, M., Kamper, P., Sørensen, B. S., Møller, M. B., Bendix, K.
, Hamilton-Dutoit, S. J., Alsner, J., D'Amore, F. A. & Honoré, B. (2015).
Differential protein expression of peroxiredoxin-1 in classical Hodgkin Lymphoma: a possible correlation to clinical behaviour.
Hematological Oncology,
33, 253-255.
https://doi.org/10.1002/hon.2157
Hansen, G. A. W.
, Ludvigsen, M., Jacobsen, C., Cangemi, C., Rasmussen, L. M., Vorum, H.
& Honoré, B. (2015).
Fibulin-1C, C1 esterase inhibitor and glucose regulated protein 75 interact with the CREC proteins, calumenin and reticulocalbin.
P L o S One,
10, Article e0132283.
Ludvigsen, M., Madsen, C.
, Kamper, P., Hamilton-Dutoit, S. J., Bendix, K.
, D'Amore, F. A. & Honoré, B. (2015).
Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma.
Blood Cancer Journal,
5, Article e293.
https://doi.org/10.1038/bcj.2015.18
Vase, M. Ø., Maksten, E. F., Strandhave, C.
, Søndergaard, E., Bendix, K.
, Hamilton Dutoit, S. J., Andersen, C., Møller, M. B., Sørensen, S. S., Kampmann, J.
, Eiskjær, H., Iversen, M.
, Weinreich, I. D., Møller, B., Jespersen, B. & D'Amore, F. A. (2015).
HLA associations and risk of posttransplant lymphoproliferative disorder in Danish population-based cohort.
Transplantation Direct,
1(7), p e25.
https://doi.org/10.1097/TXD.0000000000000534
Ristolainen, H., Kilpivaara, O.
, Kamper, P., Taskinen, M., Saarinen, S., Leppä, S.
, d'Amore, F. & Aaltonen, L. A. (2015).
Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing.
British Journal of Haematology,
170(3), 428-431.
https://doi.org/10.1111/bjh.13295
Ristolainen, H., Kilpivaara, O.
, Kamper, P., Taskinen, M., Saarinen, S., Leppä, S.
, D'Amore, F. A. & Aaltonen, L. (2015).
Identification of novel germline variants in early-onset familial classical Hodgkin lymphoma by exome sequencing.
British Journal of Haematology,
170(3), 428-31.
Andersen, R. K., Hammer, K.
, Hager, H., Christensen, J. N., Ludvigsen, M., Honoré, B., Thomsen, M.-B.
& Madsen, M. (2015).
Melanoma tumors frequently acquire LRP2/megalin expression, which modulates melanoma cell proliferation and survival rates. Pigment Cell & Melanoma Research.
https://doi.org/10.1111/pcmr.12352
Vase, M. Ø., Maksten, E. F., Bendix, K.
, Hamilton-Dutoit, S., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J.
, Søndergård, E., Nielsen, P. S. & D'amore, F. (2015).
Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders.
Leukemia and Lymphoma,
56(6), 1677-85.
https://doi.org/10.3109/10428194.2014.966242
Madsen, C.
, Pedersen, M. B., Vase, M. Ø., Bendix, K., Møller, M. B., Johansen, P., Jensen, BA., Munksgaard, L., Brown, P. D. N., Segel, E.
& D'Amore, F. A. (2015).
Outcome determinants for transformed indolent lymphomas treated with or without autologous stem cell transplantation. Annals of Oncology,
26(2), 393-9.
https://doi.org/10.1093/annonc/mdu537
Madsen, C.
, Pedersen, M. B., Vase, M. Ø., Segel, E. K., Bendix, K., Jensen, BA., Møller, M. B., Johansen, P., Munksgaard, L., Brown, P. D. N.
& D'Amore, F. A. (2015).
outcome determinats for transformed indolent lymphomas treated with or without autologous stem cell transplantation. Annals of Oncology,
26(2), 393-399.
d'Amore, F., Gaulard, P., Trümper, L., Corradini, P.
, Kim, W.-S., Specht, L., Bjerregaard Pedersen, M., Ladetto, M. & ESMO Guidelines Committee (2015).
Peripheral T-cell Lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology,
26 Suppl 5, v108-15.
https://doi.org/10.1093/annonc/mdv201
Ludvigsen, M., Kamper, P., Hamilton Dutoit, S. J., Bendix, K., Moeller, MB.
, d'Amore, F. A. & Honoré, B. (2015).
Relationship of intratumoral protein expression patterns to age and Epstein-Barr virus status in classical Hodgkin lymphoma. European Journal of Haematology,
95(2), 137-49.
Ludvigsen, M., Kamper, P., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B.
, d'Amore, F. A. & Honoré, B. (2015).
Relationship of intratumoural protein expression patterns to age and Epstein-Barr virus status in classical Hodgkin lymphoma.
European Journal of Haematology,
97, 137-149.
https://doi.org/10.1111/ejh.12463
Christensen, B.
, Ludvigsen, M., Nellemann, B., Kopchick, J. J.
, Honoré, B. & Jørgensen, J. O. L. (2015).
Serum Proteomic Changes after Randomized Prolonged Erythropoietin Treatment and/or Endurance Training: Detection of Novel Biomarkers.
PLOS ONE,
10(2), e0117119.
https://doi.org/10.1371/journal.pone.0117119
Andersen, M. D.
, Nielsen, P. S., Bendix, K., Riber-Hansen, R.
, Steiniche, T., Hamilton-Dutoit, S., Clausen, M.
& d'Amore, F. (2015).
Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
European Journal of Haematology, 252-259.
https://doi.org/10.1111/ejh.12583
Christensen, M. S., Hansen, J.
, Ramlau-Hansen, C., Toft, G., d'Amore, F. & Kolstad, H. A. (2014).
0177 Exposure to styrene and the risk of cancer: a long-term follow-up study of workers in the Danish reinforced plastics industry.
Occupational & Environmental Medicine,
71 Suppl 1, A82-3.
https://doi.org/10.1136/oemed-2014-102362.257
Zinzani, P., Coiffier, B., Radford, J., Caballero, D., Fields, P., Chamuleau, M.
, D'Amore, F. A., Haioun, C., Thieblemont, C., Barca, E., Garcia, C., Johnson, PW., Van Imhoff, G., Saunders, A., Dwyer, K. & Morschhauser, F. (2014).
A phase II open-label, multi-center study of anti-CCR4 monoclonal antibody mogamulizumab (KW-0761) in patients with previously treated peripheral t-cell lymphoma (PTCL).
Blood,
124(21).
Gisselbrecht, C., Borchmann, P.
, D'Amore, F., Illidge, T. M. & Zinzani, P. L. (2014).
Challenging CD30-positive lymphomas--current challenges, new insights and future directions: joining a conversation on CD30+ lymphomas.
Leukemia Research,
38(9), 1003.
https://doi.org/10.1016/j.leukres.2014.08.013
O'Connor, O. A., Bhagat, G., Ganapathi, K.
, Pedersen, M. B., D'Amore, F., Radeski, D. & Bates, S. E. (2014).
Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice.
Clinical Cancer Research,
20(20), 5240-54. Article e006363.
https://doi.org/10.1158/1078-0432.CCR-14-2020
Madsen, C.
, Pedersen, M. B., Vase, M. Ø., Segel, E., Bendix, K., Jensen, B. A., Jensen, P., Møller, M. B., Johansen, P., Munksgaard, L., Brown, P. D. N.
& D'Amore, F. A. (2014).
Clinical outcome determinats for sequentially transformed indolent lymphomas treated with or without autologous stem cell transplantation.
Blood,
124(21).
Gormsen, L. C., Wassberg, C., Molin, D., Kamper, P. M. H., Enblad, G.
& D'Amore, F. A. (2014).
Diffusely increased bone marrow 18F-FDG uptake is an independent predictor of focal bone lesions in patients with newly diagnosed classical Hodgkin Lymphoma.
Blood,
124(21).
Pedersen, M. B., Riber-Hansen, R.
, Nielsen, P. S., Bendix, K.
, Hamilton-Dutoit, S. J., D'Amore, F. & Steiniche, T. (2014).
Digital pathology for the validation of tissue microarrays in peripheral T-cell lymphomas.
Applied Immunohistochemistry & Molecular Morphology,
22(8), 577-84.
https://doi.org/10.1097/PAI.0b013e3182a7d16d
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B., Nørgaard, P., Johansen, P., Ralfkiaer, E., Brown, P. D. N., Hansen, P. B., Jensen, B. A., Madsen, J., Schöllkopf, C.
& d'Amore, F. (2014).
Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry.
Hematological Oncology (Online),
33(4), 120-128.
https://doi.org/10.1002/hon.2153
Christensen, M. H., Hansen, J., Ramlau-Hansen, C., Toft, G.
, D'Amore, F. A. & Kolstad, H. (2014).
Exposure to styrene and the risk of cancer: a long-term follow-up study of workers in the Danish reinforced plastics industry. Occupational & Environmental Medicine,
71(Suppl 1).
Kelsen, J., Dige, A., Christensen, M.
, D'Amore, F. & Iversen, L. (2014).
Frequency and clonality of peripheral γδ T cells in psoriasis patients receiving anti-TNF-α therapy.
Clinical and Experimental Immunology,
177(1), 142–148.
https://doi.org/10.1111/cei.12331
Petruskevicius, I.
, Ludvigsen, M., Kamper, P., Hjortebjerg, R.
, Sørensen, B. S., Nielsen, B.
, Honoré, B. & d'Amore, F. A. (2014).
Galectin-1 as a novel biomarker in haematologic malignancies treated with non-myeloablative haematopoietic stem cell transplantation.
Petruskevicius, I.
, Ludvigsen, M., Kamper, P. M. H., Hjortebjerg, R.
, Sørensen, B. S., Nielsen, B., Honoré, B.
& D'Amore, F. A. (2014).
Galectin-1 as a novel prognostic biomarker in haematologic malignancies treated with non-myeloablative haemopoietic stem cell transplantation.. Poster session presented at European Group for Blood and Marrow Transplantation Annual Meeting, Milano, Italy.
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Noerregaard, P., Moeller, MB.
, Steiniche, T. & D'Amore, F. A. (2014).
High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma.
Histopathology,
65(4), 490–500.
https://doi.org/10.1111/his.12407
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Nørgaard, P., Møller, M. B., Raffeld, M., Pittaluga, S.
, Steiniche, T., Bergmann, A., Vater, I., Siebert, R., Chan, W.-C.
& D'Amore, F. A. (2014).
Identification of a subset of peripheral T-cell lymphoma, not otherwise specified, characterized by FOXP3-positive regulatory T-cell phenotype, HTLV-1 negativity and poor outcome.
Blood,
124(21).
Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B., Raffeld, M., Pittaluga, S.
, Steiniche, T., Bergmann, A., Vater, I., Siebert, R., Chan, W. C.
& D'Amore, F. A. (2014).
Identification of a subset of perpheral T-cell lymphoma, not otherwise specified, characterized by FOXP3-positive regulatory T-cell phenotype, HTLV-1 negativity and poor outcome. Identification of a subset of perpheral T-cell lymphoma, not otherwise specified, characterized by FOXP3-positive regulatory T-cell phenotype, HTLV-1 negativity and poor outcome. .
Blood,
124(21), Article 124.
Kilpivaara, O., Ristolainen, H.
, Kamper, P., Taskinen, M., Saarinen, S., Leppä, S.
, D'Amore, F. A. & Lauri, A. A. (2014).
Identification of novel germline variants in early-onset familial classical Hodgkin lymphoma with exome sequencing.
Blood,
121(24).
D'Amore, F. A., Jørgensen, J. M., Sillesen, I. B., Segel, E., Bentzen, H. H. N., Thorsgaard, M., Pulcynski, E., Pedersen, B., Gillstrom, D., Clausen, M. R.
, Kamper, P., Silkjær, T., Gormsen, L. C., Leppä, S.
& Toldbod, H. (2014).
Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas.
Blood,
124(21).
Ludvigsen, M., Pedersen, M. B., Poulsen, T. S.
, Hamilton-Dutoit, S. J., Besenbacher, S., Bendix, K., Møller, M. B.
, D'Amore, F. A. & Honoré, B. (2014).
Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified: Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified.
Blood,
124(21), Article 124.
Abrahamsson, A., Albertsson-Lindblad, A., Brown, P. N., Baumgartner-Wennerholm, S., Pedersen, L. M.
, D'Amore, F., Nilsson-Ehle, H., Jensen, P.
, Pedersen, M., Geisler, C. H. & Jerkeman, M. (2014).
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.
Blood,
124(8), 1288-95.
https://doi.org/10.1182/blood-2014-03-559930
El-Galaly, T. C., Mylam, K. J.
, Bøgsted, M., Brown, P. D. N., Rossing, M., Gang, A. O., Haglund, A., Arboe, B., Clausen, M. R., Jensen, P.
, Pedersen, M., Bukh, A., Jensen, B. A., Poulsen, C. B.
, d'Amore, F. & Hutchings, M. (2014).
Role of routine imaging in detecting recurrent lymphoma; a review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
American Journal of Hematology,
89(6), 575-580.
https://doi.org/10.1002/ajh.23688
D'Amore, F. A., Gaulard, P., Trümper, L., Corradini, P., Kim, W.-S., Specht, L.
& Pedersen, M. B. (2014).
T-cell lymphoma:L ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow up.
Annals of Oncology.
Coiffier, B., Federico, M., Caballero, D., Dearden, C., Morschhauser, F., Jäger, U., Trümper, L., Zucca, E., Gomes da Silva, M., Pettengell, R., Weidmann, E.
, d'Amore, F., Tilly, H. & Zinzani, P. L. (2014).
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
Cancer Treatment Reviews,
40(9), 1080-1088.
https://doi.org/10.1016/j.ctrv.2014.08.001
Vase, M. Ø., Maksten, E. F., Bendix, K.
, Hamilton-Dutoit, S. J., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J., Rabinovich, G. A.
, Søndergaard, E., Nielsen, P. S. & D'Amore, F. A. (2014).
Tumor microenvironmental features and outcome in post-transplant lymphoproliferative disorder.
Blood,
124(21).
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, N. A.
, Steiniche, T., Bang, K.
, Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (ALZ) is an effective treatment for both primary and relapsed severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia.
British Journal of Dermatology,
169(2), 469-472.
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, N. A.
, Steiniche, T., Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (alz) is effective against severe chronic lymphocytic leukemia-associated paraneoplastic pemphigus (pnp).
British Journal of Dermatology,
169(2).
Nielsen, R. B., Baumgartner-Nielsen, J., Peterslund, NA.
, Steiniche, T., Bang, K.
, Deleuran, M. & D'Amore, F. A. (2013).
Alemtuzumab (ALZ) is effective against severe paraneoplastic pemphigus (PNP).
British Journal of Dermatology.